Not logged in...
About USC Norris
Research
Patient Care
CISO
Search Trials
FAQ - Trials
Contact Us - Trials
Membership
Education
Shared Resources
Support USC Norris
Outreach
Login/Logout
Contact USC Norris
Support Us
Donate
Menu
USC Norris
»
Clinical Trials
Trial 9L-16-6
A Pilot/Safety Study of sEphB4-HSA in Combination with a Hypomethylating Agent (HMA) for Patients with Relapsed or Refractory Myelodysplastic Syndrome (MDS) and AML Previously Treated with a Hypomethylating Agent
Type:
Treatment
Phase:
Phase II
Status:
Not Open (Closed)
Treatments:
Other
Randomized:
No
USC Satellite Location:
None
Defintions of terms and FAQ about clinical trials.
Trial Leaders/Researchers:
Casey O'Connell, M.D.
Other Trial Staff:
Ashot Minasyan, D.M., Meena Ibrahim, D.M.
Staff may
log in
to see study documents.
Click here to see trial eligibility criteria and further details at ClinicalTrials.gov
For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or
clinical.trials@med.usc.edu
.
To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3300.